Rituximab as a therapeutic tool in severe mixed cryoglobulinemia

Clinical Reviews in Allergy and Immunology

Volumn 34, Issue 1, 2008, Pages 111-117

  Roccatello, Dario ^a   Baldovino, Simone ^b   Rossi, Daniela ^a   Giachino, Osvaldo ^a   Mansouri, Morteza ^b   Naretto, Carla ^a   Di Simone, Debora ^b   Francica, Simona ^b   Cavallo, Roberto ^a   Alpa, Mirella ^a   Napoli, Franca ^b   Sena, Luigi M ^b  

^a S GIOVANNI BOSCO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anti CD20 monoclonal antibody; Cryoglobulinemic glomerulonephritis; Cryoglobulins; HCV syndrome; Mixed cryoglobulinemia; Rituximab

Indexed keywords

ALPHA INTERFERON; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN M; PEGINTERFERON; RHEUMATOID FACTOR; RIBAVIRIN; RITUXIMAB;

ARTERY THROMBOSIS; BONE MARROW DISEASE; CRYOGLOBULINEMIA; DRUG EFFICACY; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; HEMATURIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; KIDNEY DISEASE; NEPHRITIS; PATHOGENESIS; POLYNEUROPATHY; PROTEINURIA; RETINA ARTERY THROMBOSIS; REVIEW; ULCER; VIRUS LOAD; VIRUS VIRULENCE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; HEPATITIS C; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 49349086377     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-007-8019-0     Document Type: Review

References (49)

1. JC Brouet JP Clauvel F Danon M Klein M Seligmann 1974 Biological and clinical significance of cryoglobulins. A report of 86 cases Am J Med 57 775 778
2. M Meltzer EC Franklin K Elias 1966 Cryoglobulinemia, a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity Am J Med 40 837 856
3. PD Gorevic HJ Kassab Y Levo 1980 Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients Am J Med 69 287 308
4. G D'Amico G Colasanti F Ferrario RA Sinico 1989 Renal involvement in essential mixed cryoglobulinemia Kidney Int 35 1004 1014
5. M Pascual L Perrin E Giostra JA Schifferli 1990 Hepatitis C virus in patients with cryoglobulinemia type II Infectious Dis 162 569 575
6. JM Durand P Lefevre JR Harle 1991 Cutaneous vasculitis and cryoglobulinemia type II associated with hepatitis C virus infection Lancet 337 499 500
7. M Casato G Taliani L Pucillo 1991 Cryoglobulinemia and hepatitis C virus Lancet 337 449 453
8. R Misiani P Bellavita D Fenili 1992 Hepatitis C virus infection in patients with essential mixed cryoglobulinemia Ann Intern Med 117 573 577
9. C Ferri G Longombardo L La Civita 1992 Hepatitis C virus, autoimmune liver disease and cryoglobulinemic hepatitis J Hepatol 16 242 243
10. V Agnello RT Chung LM Kaplan 1992 A role for hepatitis C virus infection in type II cryoglobulinemia N Engl J Med 327 1490 1495
11. C Ferri M Monti L La Civita 1993 Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia Blood 82 3701 3704
12. F Invernizzi P Pioltelli R Cattaneo 1979 A long-term follow-up study in essential cryoglobulinemia Acta Haematol 61 93 99
13. A Tarantino A De Vecchi G Montagnino 1981 Renal disease in essential mixed cryoglobulinemia. Long term follow-up of 44 patients Q J Med 50 1 30
14. G Monti M Galli F Invernizzi 1995 Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinemias QJM 88 115 126
15. V Rieu P Cohen MH Andrè 2002 Characteristics and outcome of 49 patients Rheumatology 41 290 300
16. A Tarantino M Campise G Banfi 1995 Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis Kidney Int 47 618 623
17. D Roccatello A Fornasieri O Giachino 2007 Multicenter study on HCV-related cryoglobulinemic glomerulonephritis Am J Kidney Dis 49 69 82
18. D Roccatello C Isidoro G Mazzucco 1993 Role of monocytes in cryoglobulinemia-associated nephritis Kidney Int 43 1150 1155
19. C Ferri MT Mascia 2006 Cryoglobulinemic vasculitis Curr Opin Rheumatol 18 54 63
20. A Fornasieri M Li S Armelloni 1993 Glomerulonephritis induced by human IgMk-IgG cryoglobulins in mice Lab Invest 69 531 540
21. D Roccatello G Morsica G Picciotto 1997 Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinemia and hepatitis C virus (HCV) infection Clin Exp Immunol 110 9 14
22. P Pileri Y Uematsu S Campagnoli 1998 Binding of hepatitis C virus to CD81 Science 282 938 941
23. D Roccatello O Giachino A Fornasieri 2000 Forum multidisciplinare su "la sindrome HCV" G Ital Nefrol 6 654 665
24. AL Zignego F Giannelli ME Marrocchi 2000 T [14 18] translocation in chronic hepatitis C virus infection Hepatology 31 474 479
25. DG Maloney AJ Grillo-Lopez CA White 1997 IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma Blood 90 2188 2195
26. D Shan JA Ledbetter OW Press 1998 Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies Blood 91 1644 1652
27. JC Byrd CA White B Link 1999 Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity Ann Oncol 10 1525 1527
28. TD Levine A Pestronk 1999 IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab Neurology 52 1701 1704
29. MN Saleh J Gutheil M Moore 2000 A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia Semin Oncol 27 99 103
30. M Zecca P De Stefano B Nobili F Locatelli 2001 Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia Blood 97 3995 3997
31. F Zaja S De Vita C Mazzaro 2003 Efficacy and safety of rituximab in type II mixed cryoglobulinemia Blood 101 3827 3834
32. F Zaja D Russo G Fuga 1999 Rituximab for the treatment of type II mixed cryoglobulinemia Haematologica 84 1157 1158
33. A Della Rossa A Tavoni C Baldini S Bombardieri 2002 Treatment of chronic hepatitis C infection with cryoglobulinemia Curr Opin Rheum 13 231 237
34. R Misiani P Bellavita D Fenili 1994 Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus N Engl J Med 330 751 756
35. RJ Johnson DR Gretch WG Couser 1994 Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy Kidney Int 46 1700 1704
36. P Rossi T Bertani P Baio 2003 Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy Kidney Int 63 2236 2241
37. MP Manns JG McHutchison SC Gordon 2001 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 958 965
38. KL Lindsay C Trepo T Heintges 2001 A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C Hepatology 34 395 403
39. P Selby J Kohn J Raymond I Judson T McElwain 1985 Nephrotic syndrome during treatment with interferon Br Med J 290 1180
40. H Janessen J Brouwer RC Van der Mast S Schalm 1994 Suicide associated with alpha-interferon therapy for chronic viral hepatitis J Hepatol 21 241 243
41. Ferri C, Pileri S, Zignego AL (2000) Hepatitis C virus, B-cell disorders, and non-Hodgkin lymphoma. In: Goedert JJ (ed) Infectious cause of cancer. Target for intervention. Humana, Totowa, pp 349-368
42. D Roccatello G Mazzucco R Coppo 1991 Immune material processing by phagocyte cell system in cryoglobulinemia Clin Nephrol 36 114 126
43. S Margin A Craxi C Fabiano 1994 Hepatitis C viraemia in chronic liver disease: relationship to interferon alpha or corticosteroid treatment Hepatology 19 273 279
44. D Roccatello S Baldovino D Rossi 2004 Long term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinemic glomerulonephritis Nephrol Dial Transplant 19 3054 3061
45. RJ Looney 2002 Treating human autoimmune disease by depleting B cells Ann Rheum Dis 61 863 866
46. K Arzoo S Sadeghi HA Liebman 2002 Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody Rituximab Ann Rheum Dis 61 922 924
47. SP Treon KC Anderson 2000 The use of rituximab in the treatment of malignant and non-malignant plasma cell disorders Semin Oncol 27 79 85
48. RA Clynes TL Towers LG Presta JV Ravetch 2000 Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets Nat Med 6 443 446
49. D Sansonno V De Re G Lauretta 2003 Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alfa with an anti-CD20 Blood 101 3818 3826